Brief: Orgenesis Says Entered Into Clinical Study Agreement With Edith Wolfson Medical Center
01/06/2020 15:40
June 1 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS - ENTERED INTO CLINICAL STUDY AGREEMENT WITH
EDITH
WOLFSON MEDICAL CENTER, LEADING PUBLIC HOSPITAL IN ISRAEL
* ORGENESIS - UNDER AGREEMENT, PARTIES TO CONDUCT CLINICAL
STUDY
WITH GOAL OF UTILIZING, VALIDATING NUMBER OF CO'S POCARE
TECHNOLOGIES
Source text for Eikon: ID:nGNX6V2Vhz
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules